REQUEST A DEMO
Total
USD $0.00
Search more companies

Fisher Clinical Services Pte. Ltd. (Singapore)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: All Other Professional, Scientific, and Technical Services
Full name: Fisher Clinical Services Pte. Ltd. Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Primary Business Activity: research and experimental development on medical science; Secondary Business Activity: other professional, scientific and technical activities n.e.c. (providing clinical trial supply services and biopharma services)

Headquarters
38 Beach Road, #29-11 South Beach Tower, Singapore
Singapore; Singapore; Postal Code: 189767

Contact Details: Purchase the Fisher Clinical Services Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Fisher Clinical Services Pte. Ltd. report to view the information.
Outstanding Shares:
Purchase the Fisher Clinical Services Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Fisher Clinical Services Pte. Ltd. report to view the information.
Incorporation Date:
July 19, 2006
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Fisher Clinical Services Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
18.52%
Total operating revenue
18.52%
Net Profit (Loss) for the Period
3.18%
Total assets
7.06%
Total equity
13.77%
Net Profit Margin
-9.17%
Return on Equity (ROE)
-27.59%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?